首页> 外国专利> POTENTIALITY OF LAGENARIA SICERARIA OINTMENT FOR DIABETIC WOUND HEALING

POTENTIALITY OF LAGENARIA SICERARIA OINTMENT FOR DIABETIC WOUND HEALING

机译:Lagenaria Siceraria软膏对糖尿病伤口愈合的潜力

摘要

The effect of the leaves water extract of lagenaria siceraria (sweet variety) on wound healing and diabetic wound healing in Wistar albino rats was determined in comparison with Fucidin ointment 2% and Solcoseryl ointment 10% (reference ointment used in wound healing ) using excision wound healing model. In the first group (-ve control), the healing took about 12 days to be complemented whereas in the group treated with polyethylene glycol. ointment 2% (+ve control) the healing was completed within 1 1 days. In the group treated with polyethylene glycol containing L. s. aqueous extract 2%), the period of healing was diminished to 7 days whereas in group treated with Fucidin 2 % and Solcoseryl ointment 10% the healing was completed within 10 and 9 days respectively, In diabetic wound healing trial using two groups (treated and untreated group), In untreated group (Group 1) the healing was completed within 14 days with the presence of pus cells during healing period whereas in the treated group, the healing period declined to 9 days to demonstrate intelligible effect of L. s. leaves aqueous extract on diabetic wound healing. In the clinical trial all the treated volunteers (about 42) had been recovered, 100 % results was obtained. Some of the patients recovered within three days, others within 7 days whereas others take 10- 15 days. In acute oral toxicity, Lagenaria siceraria /eaves water extract didn't show any signs of toxicity during all of the observation period, no mortality or any reduction of weight has been registered during the experimental period. In topical treatment, no irritation, no corrosion or any signs of allergy or skin sensitivity against the ointment. Phytochemical screening of the leaves water extract declared presence of Polyuronide (mucillage), glucides, reducing compounds, saponins and tannins. In testing antimicrobial activity of Lagenaria siceraria leaves water extract against Staphylococcus aureus, Klebsiella pneumonia, Proteus vulgaris, Pseudomonas aeruginosa and Candida albicans, it didn't detect any activity against any of the tested organisms, lac inhibition zone declared zero reading.
机译:通过切除伤口,与2%的Fucidin软膏和10%的Solcoseryl软膏(用于伤口愈合的参考软膏)相比,确定了Wistar albino大鼠中的剑兰(甜味品种)叶片水提取物对伤口愈合和糖尿病伤口愈合的影响。修复模型。在第一组(-ve对照)中,愈合需要约12天才能得到补充,而在用聚乙二醇治疗的组中。软膏2%(+ ve对照)在1 1天内完成愈合。在用含L.s的聚乙二醇处理的组中。水提取物2%),愈合期缩短至7天,而用Fucidin 2%和Solcoseryl软膏10%处理的组分别在10天和9天内完成愈合,在糖尿病伤口愈合试验中,使用了两组(治疗组和治疗组)在未治疗组(组1)中,在愈合期间在有脓细胞存在的情况下,其愈合在14天内完成,而在治疗组中,愈合期降至9天,以证明L. s的可理解的效果。将水提取物用于糖尿病伤口愈合。在临床试验中,所有接受治疗的志愿者(约42名)均已康复,获得了100%的结果。一些患者在三天内恢复,其他患者在7天内恢复,而其他患者则需要10-15天。在急性口服毒性中,洋紫苏/ eaves水提取物在整个观察期内均未显示任何毒性迹象,在实验期间未发现死亡或体重减轻。在局部治疗中,无刺激,无腐蚀或对软膏过敏或皮肤过敏的任何迹象。叶片水提取物的植物化学筛选表明存在聚尿嘧啶酯(葡糖醛酸),葡糖苷,还原性化合物,皂苷和单宁酸。在测试洋紫苏叶水提取物对金黄色葡萄球菌,肺炎克雷伯菌,寻常变形杆菌,铜绿假单胞菌和白色念珠菌的抗菌活性时,它没有检测到对任何被测生物的任何活性,紫胶抑制区宣布为零读数。

著录项

  • 公开/公告号WO2018146504A1

    专利类型

  • 公开/公告日2018-08-16

    原文格式PDF

  • 申请/专利权人 ELAMIN IHSAN MOHAMMED ELHADI;

    申请/专利号WO2017IB00155

  • 发明设计人 ELAMIN IHSAN MOHAMMED ELHADI;

    申请日2017-02-09

  • 分类号A61K36/42;A61K9;A61P17/02;

  • 国家 WO

  • 入库时间 2022-08-21 12:43:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号